|
|
|
41
|
4331L
|
AFINITOR 5MG TAB (NVS) EVEROLIMUS (C)
|
EVEROLIMUS
|
AFINITOR
|
30'S
|
C
|
5164.82
|
172.1605
|
TAB
|
0
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
4331L
|
AFINITOR 5MG TAB (NVS) EVEROLIMUS
|
EVEROLIMUS
|
AFINITOR
|
30'S
|
C
|
5,436.65
|
181.22
|
TAB
|
0
|
BLIS
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
4331M
|
AFINITOR 10MG TAB (NVS/COL) EVEROLIMUS
|
EVEROLIMUS
|
AFINITOR
|
30'S
|
C
|
15,490.2
|
516.34
|
TABLET
|
0
|
TAB
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4331M
|
AFINITOR 10MG TAB (NVS) EVEROLIMUS (C)
|
EVEROLIMUS
|
AFINITOR
|
30'S
|
C
|
10329.63
|
344.321
|
TAB
|
0
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
4331M
|
AFINITOR 10MG TAB (NVS) EVEROLIMUS
|
EVEROLIMUS
|
AFINITOR
|
30'S
|
C
|
10,873.30
|
362.44
|
TAB
|
0
|
BLIS
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
43321
|
GLIVEC 400MG CAP (NVS/COL) IMATINIB
|
IMATINIB
|
GLIVEC
|
30'S
|
C
|
4,599.40
|
153.31
|
CAPSULE
|
0
|
CAP
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
43321
|
GLIVEC 400MG CAP (NVS) IMATINIB (SAD) (BQ)
|
IMATINIB
|
GLIVEC
|
30'S
|
BQ
|
4568.74
|
152.2914
|
CAP
|
60
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
43321
|
GLIVEC 400MG CAP (NVS) IMATINIB (SAD)
|
IMATINIB
|
GLIVEC
|
30'S
|
C
|
4,568.74
|
152.29
|
CAP
|
60
|
BLIS
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
43327
|
IMATINIB 400MG CAP (ZUV)
|
IMATINIB
|
IMATINIB
|
30'S
|
BQ
|
32.02
|
1.07
|
CAP
|
60
|
BLIS
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
4332B
|
TASIGNA 200MG CAP (NVS/COL) NILOTANIB
|
NILOTINIB
|
TASIGNA
|
112'S
|
C
|
13,233.8
|
118.16
|
CAPSULE
|
0
|
CAP
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4332B
|
TASIGNA 200MG CAP (NVS) NILOTANIB (BQ)
|
NILOTINIB
|
TASIGNA
|
112'S
|
BQ
|
10329.63
|
92.2288
|
CAP
|
0
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
4332B
|
TASIGNA 200MG CAP (NVS) NILOTANIB
|
NILOTINIB
|
TASIGNA
|
112'S
|
C
|
10,329.63
|
92.23
|
CAP
|
0
|
BLIS
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
4332K
|
APO-IMATINIB 400MG TAB (APO/COL)
|
IMATINIB
|
APO-IMATINIB
|
30'S
|
BQ
|
123.96
|
4.13
|
TABLET
|
0
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4332U
|
TYKONIB 400MG TAB (MSN) (BQ)
|
IMATINIB
|
TYKONIB
|
30'S
|
BQ
|
117.02
|
3.9008
|
TAB
|
60
|
BOTT
|
MSN
|
MSN LABS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4332Y
|
APO-IMATINIB 400MG CAP (APO) (BQ)
|
IMATINIB
|
APO-IMATINIB
|
30'S
|
BQ
|
125.21
|
4.1735
|
CAP
|
60
|
BOX
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
43519
|
BOTTLE, GLASS RX, 30ML AMBER EACH (BEA/COL)
|
BOTTLES
|
BOTTLE, GLASS RX, 30ML AMBER
|
130'S
|
B
|
43.38
|
0.33
|
|
0
|
EACH
|
BEA
|
BEATSON CLARKE & CO. LTD.,
|
COL
|
COLLINS LTD
|
|
9400
|
MEDICAL DEVICES
|
2022-04-01
|
2024-03-31
|
|
|
0
|
MEDICAL DEVICES
|
|
|
|
|
42
|
4351E
|
BOTTLE, GLASS RX, 30ML AMBER 30ML (BEA) BOTTLES
|
BOTTLES
|
BOTTLE, GLASS RX, 30ML AMBER
|
110'S
|
B
|
39.42
|
0.36
|
EACH
|
0
|
BOX
|
BEA
|
BEATSON CLARKE & CO. LTD.,
|
COL
|
AVENTA BARBADOS
|
|
9400
|
MEDICAL DEVICES
|
2026-04-01
|
2028-03-31
|
|
|
0
|
MEDICAL DEVICES
|
|
|
|
|
40
|
43528
|
BOTTLE, GLASS RX, 60ML AMBER EACH (BEA/COL)
|
BOTTLES
|
BOTTLE, GLASS RX, 60ML AMBER
|
132'S
|
B
|
52.60
|
0.40
|
|
0
|
EACH
|
BEA
|
BEATSON CLARKE & CO. LTD.,
|
COL
|
COLLINS LTD
|
|
9400
|
MEDICAL DEVICES
|
2022-04-01
|
2024-03-31
|
Price Change
|
|
0
|
MEDICAL DEVICES
|
2022-05-09
|
|
|
|
41
|
43528
|
BOTTLE, GLASS RX, 60ML AMBER EACH (BEA)
|
BOTTLES
|
BOTTLE, GLASS RX, 60ML AMBER
|
132'S
|
B
|
52.6
|
0.3985
|
EACH
|
4
|
BOX
|
BEA
|
BEATSON CLARKE & CO. LTD.,
|
COL
|
COLLINS LTD
|
|
9400
|
MEDICAL DEVICES
|
2024-04-01
|
2025-01-28
|
|
|
0
|
MEDICAL DEVICES
|
2024-12-17
|
|
|
|
41
|
4352A
|
BOTTLE, GLASS RX, 60ML AMBER (BEA) BOTTLES
|
BOTTLES
|
BOTTLE, GLASS RX, 60ML AMBER
|
81'S
|
B
|
32.28
|
0.3985
|
EACH
|
4
|
BOX
|
BEA
|
BEATSON CLARKE & CO. LTD.,
|
COL
|
COLLINS LTD
|
|
9400
|
MEDICAL DEVICES
|
2024-12-17
|
2026-03-31
|
|
|
|
MEDICAL DEVICES
|
2024-12-17
|